Amylgen

Research Services, Biotechnology research and development, Research and testing · 2 Employees
Phone Number: contact@amylgen.com
Email Address: contact@amylgen.com
  • Overview
  • Employees
Access 4 Verified Employees Profiles for AmylgenUnlock Free Contacts Now
About
Amylgen is a CRO proposing innovative in vivo models of ageing, psychiatric and neurodegenerative pathologies for the development of new medicines or nutraceuticals. Amylgen is at your service to provide quick POC for your product as a food supplement for brain health and helps you to substantiate the efficacy of your product by preclinical studies in rodent models Amylgen brings you preclinical scientific data for your product on Brain aging preservation Memory enhancement Antidepressant /anti anxiety effect Protection against Alzheimer’s disease   Amylgen has access to regulatory and clinical partners to aid in the preparation of health claims for EFSA or FDA and the commercialization of your product
Year Founded
2009
Social Media
LinkedinFacebookTwitter
Industry
Research Services, Biotechnology research and development, Research and testing, IT, Internet, R&D, Research, general
HQ Location
2196 Boulevard de la Lironde Montferrier sur Lez, 34 980, FR
Keywords
in vivo pharmacologyBehavioral pharmacologyeurodegenerative diseasesCentral nervous system
Location
  • 2196 Boulevard de la Lironde Montferrier sur Lez, 34 980, FR

Email Formats

Sign up for free credits and discover verified email addresses of Amylgen
FormatExamples
first + last
andywarhol@amylgen.com
first_initial + last
awarhol@amylgen.com
first + last_initial
andyw@amylgen.com
first
andy@amylgen.com
last
warhol@amylgen.com
Get Verified Emails for 4 Amylgen Employees

Frequently Asked Questions

Learn More about Amylgen

Similar Companies

Research Services, Biotechnology research and development, Research and testing

Get key business info for Amylgen and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.